If you have a fecal immunochemical test (FIT) and you test positive, you will need to undergo a follow-up colonoscopy. Based on the findings of a new study, don't delay.
People with inflammatory bowel disease (IBD) often view their gastroenterologist as their primary care provider, and tend not to see a primary care provider very often. A recent clinical guideline from the American College of Gastroenterology, however, suggests that people with IBD would benefit from coordinated care, where the gastroenterologist and the primary care provider keep each other informed of their patients' health status and needs.
Are you a meat-and-potatoes kind of guy? A 2017 study in the journal GUT suggests that men who regularly eat red meat—beef, pork, lamb, particularly in unprocessed forms (as opposed to deli meats and sausages)—have an increased risk of developing diverticulitis.
Eating a mostly vegetarian diet may be as effective as taking a proton pump inhibitor (PPI) to relieve symptoms of a form of stomach acid reflux called laryngopharyngeal reflux (LPR), according to a new study.
Gluten has gotten a bad rap in recent years. As a consequence, low- and gluten-free diets have become popular, with people speculating that the consumption of wheat and other gluten-rich grains has negative effects on their health. But at this point, that's all it is-speculation.
If you have a parent, sibling, or child with celiac disease, you should be tested for it, even if you don't have symptoms or signs of the condition, according to a 2017 review article in the Journal of the American Medical Association.
If you've heard of the relatively new screening test for colorectal cancer called Cologuard, you may be wondering whether it is a good—or even the "best"-option, especially if you want to avoid a colonoscopy.
The evolution of drug therapies for inflammatory bowel disease (IBD) over the past couple of decades has been a game changer for people with Crohn's disease (CD) and ulcerative colitis (UC). While older drug therapies may have been able to control symptoms, the more sophisticated agents actually move patients toward disease remission and better outcomes in the long term.
The demand for proton pump inhibitors is driven mostly by the need to control symptoms in the growing population of people with gastroesophageal reflux disease (GERD). The drugs' ongoing popularity may also stem from the prevailing belief that proton pump inhibitors have few side effects. However, increasing evidence suggests proton pump inhibitors may not be as benign as people think, over time.
The specter of infection looms over all healthcare to some degree. But in recent years, a number of small outbreaks of sometimes fatal microbial infections in people undergoing endoscopy have drawn media attention—and increased scrutiny from the U.S. Food and Drug Administration (FDA)—on the use of reprocessed endoscopes.